Browsing by Author Anforth, Rachael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2014Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinibAnforth, Rachael; Clements, Arthur; Fernandez Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Nguyen, Bao; Liu, Michael; Uribe, Pablo; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Nepean Clinical School: MedicineAcneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib, The Australasian Journal of Dermatology, vol.55, 4, 2014,pp 250-254
2015Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeksAnforth, Rachael; Carlos, Giuliana R M; Clements, Arthur; Fernandez Penas, Pablo; Kefford, Richard (Rick); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteCutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks, British Journal of Dermatology, vol.172, 1, 2015,pp 239-243
2017Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and ManagementAnforth, Rachael; Carlos Minano, Giuliana; Fernandez Penas, Pablo; Hwang, Shelley; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management, Actas Dermo-Sifiliograficas, vol.108, 1, 2017,pp 6-16
2012Cutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic MelanomaAnforth, Rachael; Fernandez-Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Scolyer, Richard; Blumetti, Tatiana Cristina Moraes Pinto; Kossard, Steven; Sharma, Raghwa; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyCutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic Melanoma, British Journal of Dermatology, vol.167, 5, 2012,pp 1153-1160
2015Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic MelanomaAnforth, Rachael; Carlino, Matteo; Carlos, Giuliana R M; Clements, Arthur; Fernandez Penas, Pablo; Menzies, Alexander Maxwel; Chou, Shaun; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineCutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma, JAMA Dermatology, vol.151, 10, 2015,pp 1103-1109
2013Cutaneous toxicities of RAF inhibitorsAnforth, Rachael; Fernandez-Penas, Pablo; Long, Georgina; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreCutaneous toxicities of RAF inhibitors, Lancet Oncology, vol.14, 1, 2013,pp e11-e18
2015Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanomaAnforth, Rachael; Carlos, Giuliana R M; Fernandez Penas, Pablo; Scolyer, Richard; Chou, Shaun; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyEruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma, Melanoma Research, vol.25, 1, 2015,pp 91-94
2015Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapyAnforth, Rachael; Byth Wilson, Karen; Carlos, Giuliana R M; Fernandez Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Sharma, Raghwa; Chou, Shaun; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Western Clinical School: PathologyFactors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy, Journal Of The American Academy Of Dermatology, vol.72, 5, 2015,pp 809-815.e1
2017Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational studyAnforth, Rachael; Fernandez Penas, Pablo; Hwang, Shelley; Zhao, Cathy Yunjia; Carlos, Giuliana; Wakade, Deepal; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Concord Clinical School: MedicineMelanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study, Australasian Journal of Dermatology, vol.58, 4, 2017,pp 292-298
2012Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking braf inhibitorsAnforth, Rachael; Blumetti, Tatiana; Fernandez-Penas, Pablo; Tembe, Varsha; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking braf inhibitors, Pigment Cell and Melanoma Research, vol.25, 5, 2012,pp 569-572
2014Panniculitis in Patients Treated With BRAF Inhibitors: A Case SeriesAnforth, Rachael; Choy, Bonita; Fernandez Penas, Pablo; Chou, Shaun; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Panniculitis in Patients Treated With BRAF Inhibitors: A Case Series, American Journal Of Dermatopathology, vol.36, 6, 2014,pp 493-497